Showing results (51-60 of 210,190) with videos related to

Sort By:
Pageof 21,019
Oncology Reports|May 25, 2011
Inhibition of vascular endothelial growth-factor induced cell-growth by an angiogenesis inhibitor agm-1470 in capillary endothelial-cellsM Toi, T Takayanagi, R Souma, et al.
International Journal of Cancer|July 5, 2018
Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory networkMarina Kiso, Sunao Tanaka, Shigehira Saji, et al.
Hepato-Gastroenterology|October 26, 2002
Impact of selective Glisson transection on survival of hepatocellular carcinomaKoji Tsuruta, Atsutake Okamoto, Masakazu Toi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Trastuzumab treatment for breast cancer]Hiroyasu Yamashiro, Kazumi Toyama, Hiroko Bando, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 19, 2015
[Leanness, obesity, and breast cancer risk-different impact of body weight on breast cancer risk according to women's life stages]Reiko Suzuki, Shigehira Saji
The International Journal of Biological Markers|June 22, 2013
Potential clinical applications of matrix metalloproteinase inhibitors and their future prospectsWenzhao Li, Shigehira Saji, Fumiaki Sato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patientsY Yamamoto, M Toi, S Kondo, et al.
Cancer Science|January 15, 2011
Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibitionMasakazu Toi, Shigehira Saji, Norikazu Masuda, et al.
Breast Cancer (Tokyo, Japan)|May 12, 2025
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in JapanMinoru Miyashita, Hiraku Kumamaru, Naoki Hayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1997
[The feasibility of CEF (cyclophosphamide, epirubicin, 5-FU) regimen in the adjuvant setting of primary breast cancer]S Honda, M Toi, S Shimizu, et al.
Pageof 21,019